Videos

Dr Seán McMahon explains how Ashland’s Viatel™ bioresorbable work and rationalizes why formulators should consider using in the development of long acting injectables and implants.

Ashland Launches Viatel™ Ultrapure Bioresorbable Polymers for LAIIs

Enrico Barichello, Product Manager for the Syringe Platform at Stevanato Group, discusses the risks associated with the interaction between primary packaging and complex novel therapeutics and describes how to prevent or manage concerns utilizing newer, pre-sterilized syringe systems that have more unique characteristics. 

How to De-risk the Development of Highly Sensitive Injectables Using High-Performance Pre-fillable Syringe Systems   

Catalent's Martin De Brauwere and Maria Lopez react to cell therapy innovations and highlight strategies to optimize the drug development and manufacturing process with assistance from a CDMO.

Solutions to Optimize Cell Therapy Development and Manufacturing

Associates of Cape Cod, Inc. & Waters Corporation Automation Collaboration

Interview with BioVectra’s Marc Sauer  at DCAT   

Interviews with Tim Tyson of TriRx at DCAT 

CAR-T Cell Therapies Entering the Mainstream of Cancer Clinical Trials & Treatment

Interview with Rentschler Biopharma's Federico Pollano

Interview with Lonza’s Sean Diver at DCAT 

Setting Allegheny Bradford Apart

Interviews with Actylis at DCAT 

PSG® Biotech Debuts BioProTT™ FlowSU System for Single-Use Biopharma Applications

Interview with Pharmatech Associates’s Richard Steiner

Frequently Asked Questions about Combination Products

Interview with Bormioli Pharma’s Andrea Lodetti at DCAT 

Interview with Jubilant’s President Chris Preti 

Sponsored Videos